☰

Robert Zamboni - Publications

Affiliations: 
Merck, Semoy, Centre-Val de Loire, France 
Tree Info Similar researchers PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Li L, Beaulieu C, Carriere MC, Denis D, Greig G, Guay D, O'Neill G, Zamboni R, Wang Z. Potent and highly selective DP1 antagonists with 2,3,4,9-tetrahydro-1H-carbazole as pharmacophore. Bioorganic & Medicinal Chemistry Letters. 20: 7462-5. PMID 21036609 DOI: 10.1016/J.Bmcl.2010.10.018  0.323
2010 Guay D, Beaulieu C, Truchon JF, Reddy TJ, Bayly CI, Zamboni R, Methot N, Rubin J, Ethier D, Percival MD. Corrigendum to "Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C" [Bioorg. Med. Chem. Lett. 19 (2009) 5392] (DOI:10.1016/j.bmcl.2009.07.114) Bioorganic and Medicinal Chemistry Letters. 20: 1463. DOI: 10.1016/J.Bmcl.2010.01.019  0.337
2009 Guay D, Beaulieu C, Truchon JF, Jagadeeswar Reddy T, Zamboni R, Bayly CI, Methot N, Rubin J, Ethier D, David Percival M. Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C. Bioorganic & Medicinal Chemistry Letters. 19: 5392-6. PMID 19665376 DOI: 10.1016/J.Bmcl.2009.07.114  0.346
2008 Beaulieu C, Guay D, Wang Z, Leblanc Y, Roy P, Dufresne C, Zamboni R, Berthelette C, Day S, Tsou N, Denis D, Greig G, Mathieu MC, O'Neill G. Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold. Bioorganic & Medicinal Chemistry Letters. 18: 2696-700. PMID 18359630 DOI: 10.1016/J.Bmcl.2008.03.015  0.301
2007 Sturino CF, O'Neill G, Lachance N, Boyd M, Berthelette C, Labelle M, Li L, Roy B, Scheigetz J, Tsou N, Aubin Y, Bateman KP, Chauret N, Day SH, Lévesque JF, ... ... Zamboni R, et al. Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524). Journal of Medicinal Chemistry. 50: 794-806. PMID 17300164 DOI: 10.1021/Jm0603668  0.331
2007 Nicoll-Griffith DA, Seto C, Aubin Y, Lévesque JF, Chauret N, Day S, Silva JM, Trimble LA, Truchon JF, Berthelette C, Lachance N, Wang Z, Sturino C, Braun M, Zamboni R, et al. In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites. Bioorganic & Medicinal Chemistry Letters. 17: 301-4. PMID 17095220 DOI: 10.1016/J.Bmcl.2006.10.055  0.337
2004 Becker JW, Rotonda J, Soisson SM, Aspiotis R, Bayly C, Francoeur S, Gallant M, Garcia-Calvo M, Giroux A, Grimm E, Han Y, McKay D, Nicholson DW, Peterson E, Renaud J, ... ... Zamboni R, et al. Reducing the peptidyl features of caspase-3 inhibitors: a structural analysis. Journal of Medicinal Chemistry. 47: 2466-74. PMID 15115390 DOI: 10.1021/Jm0305523  0.306
2001 Asante-Appiah E, Ball K, Bateman K, Skorey K, Friesen R, Desponts C, Payette P, Bayly C, Zamboni R, Scapin G, Ramachandran C, Kennedy BP. The YRD motif is a major determinant of substrate and inhibitor specificity in T-cell protein-tyrosine phosphatase. The Journal of Biological Chemistry. 276: 26036-43. PMID 11352902 DOI: 10.1074/Jbc.M011697200  0.326
2000 Nicoll-Griffith DA, Yergey JA, Trimble LA, Silva JM, Li C, Chauret N, Gauthier JY, Grimm E, Léger S, Roy P, Thérien M, Wang Z, Prasit P, Zamboni R, Young RN, et al. Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx). Bioorganic & Medicinal Chemistry Letters. 10: 2683-6. PMID 11128651 DOI: 10.1016/S0960-894X(00)00538-2  0.357
1999 Prasit P, Wang Z, Brideau C, Chan CC, Charleson S, Cromlish W, Ethier D, Evans JF, Ford-Hutchinson AW, Gauthier JY, Gordon R, Guay J, Gresser M, Kargman S, Kennedy B, ... ... Zamboni R, et al. The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor. Bioorganic & Medicinal Chemistry Letters. 9: 1773-8. PMID 10406640 DOI: 10.1016/S0960-894X(99)00288-7  0.322
1999 Ouimet N, Chan CC, Charleson S, Claveau D, Gordon R, Guay D, Li CS, Ouellet M, Percival DM, Riendeau D, Wong E, Zamboni R, Prasit P. Substituted heterocyclic analogs as selective COX-2 inhibitors in the flosulide class. Bioorganic & Medicinal Chemistry Letters. 9: 151-6. PMID 10021918 DOI: 10.1016/S0960-894X(98)00705-7  0.34
1999 Desmarais S, Friesen RW, Zamboni R, Ramachandran C. [Difluro(phosphono)methyl]phenylalanine-containing peptide inhibitors of protein tyrosine phosphatases. The Biochemical Journal. 337: 219-23. PMID 9882618 DOI: 10.1042/Bj3370219  0.301
1997 Scheigetz J, Gilbert M, Zamboni R. Synthesis of fluorescein phosphates and sulfates Organic Preparations and Procedures International. 29: 561-568. DOI: 10.1080/00304949709355232  0.323
1996 Belley ML, Hill B, Mitenko H, Scheigetz J, Zamboni R. Asymmetric Dihydroxylation of Dienes: Synthesis of Tetrols Synlett. 1996: 92-94. DOI: 10.1055/S-1996-5323  0.345
1995 Scheigetz J, Zamboni R, Roy B. Synthesis of 5-methanesulfonamido-6-(2,4-difluorophenylthio)-1-indanone Synthetic Communications. 25: 2791-2806. DOI: 10.1080/00397919508011826  0.345
1995 Scheigetz J, Zamboni R, Bernstein MA, Roy B. A synthesis of 4-α-guanidino-2-deoxy-2, 3-didehydro n-acetylneuraminic acid Organic Preparations and Procedures International. 27: 637-644. DOI: 10.1080/00304949509458521  0.329
1995 Lau CK, Dufresne C, Gareau Y, Zamboni R, Labelle M, Young RN, Metters KM, Rochette C, Sawyer N, Slipetz DM, Charette L, Jones T, McAuliffe M, McFarlane C, Ford-Hutchinson AW. Evolution of a series of non-quinoline leukotriene D4 receptor antagonist; synthesis and sar of benzothiazoles and thiazoles substituted benzyl alcohols as potent LTD4 antagonists Bioorganic and Medicinal Chemistry Letters. 5: 1615-1620. DOI: 10.1016/0960-894X(95)00265-U  0.349
1994 Li C, Leblanc Y, Zamboni R, Young RN. Synthesis of an [125I]-labelled derivative of MK-571, a tool for LTD4 receptor studies Journal of Labelled Compounds and Radiopharmaceuticals. 34: 537-544. DOI: 10.1002/Jlcr.2580340607  0.354
1993 Gareau Y, Zamboni R, Wong AW. Total synthesis of N-methyl LTC4: a novel methodology for the monomethylation of amines The Journal of Organic Chemistry. 58: 1582-1585. DOI: 10.1021/Jo00058A049  0.329
1992 Zamboni R, Belley M, Champion E, Charette L, DeHaven R, Frenette R, Gauthier JY, Jones TR, Leger S, Masson P. Development of a novel series of styrylquinoline compounds as high-affinity leukotriene D4 receptor antagonists: synthetic and structure-activity studies leading to the discovery of (+-)-3-[[[3-[2-(7-chloro-2-quinolinyl)-(E)-ethenyl]phenyl][[3- (dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid. Journal of Medicinal Chemistry. 35: 3832-44. PMID 1331447 DOI: 10.1021/Jm00099A011  0.343
1992 Prasit P, Belley M, Brideau C, Chan C, Charleson S, Evans JF, Fortin R, Ford-Hutchinson AW, Gillard JW, Guay J, Hutchinson JH, Léger S, Riendeau D, Young RN, Zamboni R. A new class of leukotriene biosynthesis inhibitors: The discovery of MK0591 Bioorganic & Medicinal Chemistry Letters. 2: 1395-1398. DOI: 10.1016/S0960-894X(00)80520-X  0.32
1991 Prasit P, Belley M, Evans JF, Gauthier JY, Léveillé C, McFarlane CS, MacIntyre E, Peterson L, Piechuta H, Thérien M, Young RN, Zamboni R. A new class of leukotriene biosynthesis inhibitors: The development of ((4-(4-chlorophenyl)-1-(4-(2-quinolinylmethoxy)phenyl)butyl)thio)acetic acid, L-674,636 Bioorganic & Medicinal Chemistry Letters. 1: 645-648. DOI: 10.1016/S0960-894X(01)81169-0  0.35
1990 Williams HWR, Young RN, Zamboni R, Shaw DRD. Synthesis of [35s]‐labelled MK‐0571, a potent antagonist of LTD4 Journal of Labelled Compounds and Radiopharmaceuticals. 28: 297-306. DOI: 10.1002/Jlcr.2580280306  0.384
1989 Jones TR, Zamboni R, Belley M, Champion E, Charette L, Ford-Hutchinson AW, Frenette R, Gauthier JY, Leger S, Masson P. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Canadian Journal of Physiology and Pharmacology. 67: 17-28. PMID 2540892 DOI: 10.1139/Y89-004  0.305
1988 Guindon Y, Delorme D, Lau CK, Zamboni R. Total synthesis of LTB4 and analogs Journal of Organic Chemistry. 53: 267-275. DOI: 10.1021/Jo00237A008  0.348
1986 Evans J, Nathaniel D, Charleson S, Léveillé C, Zamboni R, Leblanc Y, Frenette R, Fitzsimmons BJ, Leger S, Hamel P. Neutrophil LTA4 hydrolases and leukotriene B4 receptors: effects of leukotriene epoxides and their enzymatic products. Prostaglandins, Leukotrienes, and Medicine. 23: 167-71. PMID 3020583 DOI: 10.1016/0262-1746(86)90181-2  0.318
1986 Young RN, Champion E, Gauthier JY, Jones TR, Leger S, Zamboni R. Stereoselective synthesis of some acetylenic analogues of leukotrienes A and D Tetrahedron Letters. 27: 539-542. DOI: 10.1016/S0040-4039(00)84034-4  0.36
1984 Rokach J, Hayes EC, Girard Y, Lombardo DL, Maycock AL, Rosenthal AS, Young RN, Zamboni R, Zweerink HJ. The development of sensitive and specific radioimmunoassays for leukotrienes. Prostaglandins, Leukotrienes, and Medicine. 13: 21-5. PMID 6324239 DOI: 10.1016/0262-1746(84)90098-2  0.326
1983 Rollins TE, Zanolari B, Springer MS, Guindon Y, Zamboni R, Lau CK, Rokach J. Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN. Prostaglandins. 25: 281-9. PMID 6304818 DOI: 10.1016/0090-6980(83)90110-7  0.312
1983 Zamboni R, Rokach J. Synthesis of the aza analog of LTA4 Tetrahedron Letters. 24: 331-334. DOI: 10.1016/S0040-4039(00)81399-4  0.337
1982 Zamboni R, Rokach J. Simple efficient synthesis of LTB4 and 12-epi-LTB4 Tetrahedron Letters. 23: 2631-2634. DOI: 10.1016/S0040-4039(00)87415-8  0.305
1982 Guindon Y, Zamboni R, Lau CK, Rokach J. Stereospecific synthesis of leukotriene B4 (LTB4) Tetrahedron Letters. 23: 739-742. DOI: 10.1016/S0040-4039(00)86935-X  0.313
1981 Rokach J, Lau CK, Zamboni R, Guindon Y. A C-glycoside route to leukotrienes Tetrahedron Letters. 22: 2763-2766. DOI: 10.1016/S0040-4039(01)90546-5  0.314
1981 Rokach J, Zamboni R, Lau CK, Guindon Y. The stereospecific synthesis of leukotriene A4 (LTA4), 5-epi-LTA4, 6-epi-LTA4 and 5-epi,6-epi-LTA4 Tetrahedron Letters. 22: 2759-2762. DOI: 10.1016/S0040-4039(01)90545-3  0.34
1979 Zamboni R, Just G. β-Lactams. VII. The synthesis of 3-vinyl and 3-isopropenyl 4-substituted azetidinones Canadian Journal of Chemistry. 57: 1945-1948. DOI: 10.1139/V79-312  0.544
1979 Just G, Ugolini A, Zamboni R. β-Lactams. IV. cis-Fused β-Lactams from Substituted Cinnamylidene Anilines and Azidoacetyl Chloride: Scope and Limitations Synthetic Communications. 10: 117-121. DOI: 10.1080/00397917908064139  0.507
1979 Zamboni R, Just G. β-LACTAMS. VII. THE SYNTHESIS OF 3-VINYL- AND 3-ISOPROPENYL-4-SUBSTITUTED-AZETIDINONES Cheminform. 10. DOI: 10.1002/Chin.197951206  0.546
1978 Just G, Zamboni R. β-Lactams. III. The synthesis of 7-β-phenyiacetamido-3′-carboxybenzo[3,4]-O-2-isocephem Canadian Journal of Chemistry. 56: 2725-2730. DOI: 10.1139/V78-449  0.511
1978 Just G, Zamboni R. β-Lactams. II. The synthesis of cis-N-(2′-carboxyphenyl)-3-N-phenylacetamido-4-methoxymethyl-2-azetidinone Canadian Journal of Chemistry. 56: 2720-2724. DOI: 10.1139/V78-448  0.546
Show low-probability matches.